Autopsy data from 808 participants in the National Alzheimer's Coordinating Center found that when vascular brain injury sat alongside Alzheimer's disease neuropathologic change, cognitive decline was worse than Alzheimer's change alone in only one of five domains tested, and slower than would be expected if the two pathologies acted independently. The study, by Sarah M Yasuda and colleagues at the University of Washington, was published online in the Journal of Neuropathology and Experimental Neurology on 23 April 2026. By contrast, Alzheimer's change plus Lewy body disease was worse than Alzheimer's change alone in four of the five domains, and in all four the rate of decline was consistent with an additive model. Alzheimer's change plus LATE-NC, the limbic-predominant age-related TDP-43 encephalopathy now recognised in many older brains, was worse in three domains: additive in one, less than additive in two.
This was an observational clinicopathologic study, not a trial. Participants were followed at US Alzheimer's Disease Research Centers, took a standard neuropsychological battery at annual visits during life, and had a standardised brain examination after death; all were 65 or older when they died. Trajectories in overall cognition, episodic memory, attention, language and executive function were modelled with linear mixed-effects methods, then compared with the trajectory each combination would have produced if the pathologies simply summed. Vascular brain injury was defined at autopsy as any gross infarct in the cerebral cortex, subcortical or periventricular white matter or subcortical gray matter, or two or more microinfarcts in those regions.
The combinations are not rare. Among the 922 participants with data on all four pathologies, 74.5 per cent (687) had Alzheimer's change, 29.4 per cent (271) had vascular brain injury, 25.6 per cent (236) had LATE-NC and 12.6 per cent (116) had Lewy body disease; 44.0 per cent (406) had more than one, the two commonest pairings being Alzheimer's change with LATE-NC (125) and Alzheimer's change with vascular injury (119). That matters for the word families hear most often. "Mixed" is usually delivered as a warning that things will move faster, yet on these figures the mixture most often present in clinic was the mildest modifier of the rate of decline, while the less common Lewy body combination was the one that behaved like arithmetic.
The direction is not new. A 2017 analysis in Neurology of 1,603 autopsied participants at the same network of centres reported that people with Alzheimer's change plus vascular injury typically had less impairment and slower decline than other groupings, with decline slower than an additive model predicted. The limits are real in both. Research centre volunteers are not a cross-section of the population; the pathologies were confirmed only after death, so no one knew during life which mixture they had; brains carrying three or more of the four pathologies were excluded from the trajectory analysis; and averages across a group say nothing certain about one person's next two years. The authors frame the findings as relevant to prognostication in clinical practice and to clinical trial design.